Today, we honor the strength and resilience of those who have faced cancer. At Sana, we are dedicated to developing cures for patients with cancer and other serious diseases. Together, we celebrate National Cancer Survivor's Day and commit to a future of hope and healing. #CancerSurvivorsDay #LifeBeyondCancer
Sana Biotechnology, Inc.’s Post
More Relevant Posts
-
Wishing everyone a joyful and safe Independence Day! #4thofJuly #IndependenceDay
To view or add a comment, sign in
-
-
"Juneteenth has never been a celebration of victory, or an acceptance of the way things are. Instead, it's a celebration of progress. It's an affirmation that despite the most painful parts of our history, things do get better. America can change." — Barack Obama, 44th President of the United States, Civil Rights Attorney #Juneteenth #DiversityMatters
To view or add a comment, sign in
-
-
Pride month is not only a time to celebrate and honor Sana’s LGBTQIA+ employees and community, but also a time to acknowledge that there is still more work to be done to support equal rights. At Sana, we aspire to change the possible for patients, regardless of gender, identity, or sexual orientation. #Pride #Inclusivity #Kindness #LGBTQIA #DiversityMatters
To view or add a comment, sign in
-
-
We’re excited to sponsor the Federation of American Societies for Experimental Biology (FASEB)’s Genome Engineering: Research and Applications conference taking place June 16-20, 2024, in Rome, Italy. The conference will focus on groundbreaking research, innovative tools, and cutting-edge technologies in genome and epigenome editing. The Sana team eagerly anticipates connecting with peers and staying at the forefront of industry advancements. Learn more about the conference here: https://lnkd.in/gzHqfTXB hashtag #GENESRC
To view or add a comment, sign in
-
-
Steve Harr, MD, Sana’s President and CEO, will discuss the latest updates from Sana in a fireside chat at the Goldman Sachs 45th Annual Healthcare Conference on Monday, June 10, 2024 at 2:40 p.m. ET. Listen to the live or archived discussion here: https://lnkd.in/gFnFMcUD #Sanabiotechnology #Cellengineering #CellTherapy
To view or add a comment, sign in
-
We are pleased to share that preclinical data demonstrating that healthy transplanted human glial cells replaced diseased glial cells in the brains of human glial chimeric Huntingtin mice were published and featured as the May 2024 cover story in Nature Biotechnology. These data establish additional proof-of-concept for the development of SC379, Sana’s pluripotent stem cell-derived GPC product candidate, as a potential therapy to deliver healthy allogeneic GPCs to patients with certain central nervous system disorders. Learn more in the full press release here: https://lnkd.in/gbyXCqjN
To view or add a comment, sign in
-
-
At Sana, we are dedicated to developing cures for patients with cancer and other serious diseases. This #CancerResearchMonth, join us in raising awareness and supporting the ongoing efforts that continue to pave the way for new cancer treatments. Learn how you can join the fight against cancer here: https://lnkd.in/d6QV2xz #ResearchSavesLive #NCRM24
Get Involved
https://www.aacr.org
To view or add a comment, sign in
-
Patient care is at the focus of everything we do at Sana. We are proud to honor the employees who have demonstrated a relentless spirit and focus to help our therapies reach patients. Congratulations to all of our employees who have been promoted in 2024!
To view or add a comment, sign in
-
-
Steve Harr, MD, Sana’s President and CEO, will discuss the latest updates from Sana in a fireside chat at the BofA Securities 2024 Healthcare Conference on Tuesday, May 14, 2024 at 3:00 p.m. PT. Listen to the live or archived discussion here: https://lnkd.in/gFnFMcUD #Sanabiotechnology #Cellengineering #CellTherapy
Events and Presentations | Sana Biotechnology, Inc
ir.sana.com
To view or add a comment, sign in